The World Gastroenterology Organization guidelines recommend antacids as appropriate OTC treatment options for infrequent, mild, or moderate symptoms of heartburn.

The studies provide strong evidence for Ambroxol's efficacy and safety as a non-prescription therapy for children with respiratory diseases. It's favorable benefit/risk profile extends across all age groups, including neonates, with acute and chronic respiratory conditions.

Based on the available scientific evidence, cholecalciferol is the form of vitamin D that can ensure that the vast majority of patients with vitamin D deficiency are within the optimal range of efficacy and safety in a long term period.